265 related articles for article (PubMed ID: 11020712)
1. Temporally controlled somatic mutagenesis in smooth muscle.
Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
[TBL] [Abstract][Full Text] [Related]
2. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
3. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
4. Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.
Zadelaar SM; Boesten LS; Pires NM; van Nieuwkoop A; Biessen EA; Jukema W; Havekes LM; van Vlijmen BJ; Willems van Dijk K
Transgenic Res; 2006 Feb; 15(1):31-6. PubMed ID: 16475008
[TBL] [Abstract][Full Text] [Related]
5. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.
Vasioukhin V; Degenstein L; Wise B; Fuchs E
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8551-6. PubMed ID: 10411913
[TBL] [Abstract][Full Text] [Related]
6. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
[TBL] [Abstract][Full Text] [Related]
7. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
8. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
Brocard J; Warot X; Wendling O; Messaddeq N; Vonesch JL; Chambon P; Metzger D
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14559-63. PubMed ID: 9405652
[TBL] [Abstract][Full Text] [Related]
9. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
[TBL] [Abstract][Full Text] [Related]
11. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
12. A New Autosomal
Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
[TBL] [Abstract][Full Text] [Related]
13. Inducible site-specific recombination in myelinating cells.
Doerflinger NH; Macklin WB; Popko B
Genesis; 2003 Jan; 35(1):63-72. PubMed ID: 12481300
[TBL] [Abstract][Full Text] [Related]
14. Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases.
Feil S; Krauss J; Thunemann M; Feil R
Methods Mol Biol; 2014; 1194():113-39. PubMed ID: 25064100
[TBL] [Abstract][Full Text] [Related]
15. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
[TBL] [Abstract][Full Text] [Related]
16. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
[TBL] [Abstract][Full Text] [Related]
17. Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
Bex A; Vooijs M; Horenblas S; Berns A
J Urol; 2002 Dec; 168(6):2641-4. PubMed ID: 12442001
[TBL] [Abstract][Full Text] [Related]
18. Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ.
Rautureau Y; Paradis P; Schiffrin EL
Methods Mol Biol; 2017; 1527():381-407. PubMed ID: 28116732
[TBL] [Abstract][Full Text] [Related]
19. Targeted somatic mutagenesis in mouse epidermis.
Indra AK; Li M; Brocard J; Warot X; Bornert JM; Gérard C; Messaddeq N; Chambon P; Metzger D
Horm Res; 2000; 54(5-6):296-300. PubMed ID: 11595821
[TBL] [Abstract][Full Text] [Related]
20. A mouse tool for conditional mutagenesis in ovarian granulosa cells.
Grabner B; Blaas L; Musteanu M; Hoffmann T; Birbach A; Eferl R; Casanova E
Genesis; 2010 Oct; 48(10):612-7. PubMed ID: 20715176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
